miR-34a expression, epigenetic regulation, and function in human placental diseases

References

• Sibai BM. Thrombophilia and severe preeclampsia: time to screen and treat in future pregnancies?. Hypertension 2005; 46:1252 - 3; http://dx.doi.org/10.1161/01.HYP.0000188904.47575.7e; PMID: 16286582
   PubMed Web of Science ®Google Scholar
• Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005; 308:1592 - 4; http://dx.doi.org/10.1126/science.1111726; PMID: 15947178
   PubMed Web of Science ®Google Scholar
• Astedt B, Lindoff C, Lecander I. Significance of the plasminogen activator inhibitor of placental type (PAI-2) in pregnancy. Semin Thromb Hemost 1998; 24:431 - 5; http://dx.doi.org/10.1055/s-2007-996035; PMID: 9834009
   PubMed Web of Science ®Google Scholar
• Chelbi ST, Mondon F, Jammes H, Buffat C, Mignot TM, Tost J, Busato F, Gut I, Rebourcet R, Laissue P, et al. Expressional and epigenetic alterations of placental serine protease inhibitors: SERPINA3 is a potential marker of preeclampsia. Hypertension 2007; 49:76 - 83; http://dx.doi.org/10.1161/01.HYP.0000250831.52876.cb; PMID: 17088445
   PubMed Web of Science ®Google Scholar
• Auer J, Camoin L, Guillonneau F, Rigourd V, Chelbi ST, Leduc M, Laparre J, Mignot TM, Vaiman D. Serum profile in preeclampsia and intra-uterine growth restriction revealed by iTRAQ technology. J Proteomics 2010; 73:1004 - 17; http://dx.doi.org/10.1016/j.jprot.2009.12.014; PMID: 20079470
   PubMed Web of Science ®Google Scholar
• Chelbi ST, Wilson ML, Veillard AC, Ingles SA, Zhang J, Mondon F, Gascoin-Lachambre G, Doridot L, Mignot TM, Rebourcet R, et al. Genetic and epigenetic mechanisms collaborate to control SERPINA3 expression and its association with placental diseases. Hum Mol Genet 2012; 21:1968 - 78; http://dx.doi.org/10.1093/hmg/dds006; PMID: 22246292
   PubMed Web of Science ®Google Scholar
• Davis BN, Hata A. Regulation of MicroRNA Biogenesis: A miRiad of mechanisms. Cell Commun Signal 2009; 7:18; http://dx.doi.org/10.1186/1478-811X-7-18; PMID: 19664273
   PubMed Web of Science ®Google Scholar
• van Rooij E, Olson EN. MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets. J Clin Invest 2007; 117:2369 - 76; http://dx.doi.org/10.1172/JCI33099; PMID: 17786230
   PubMed Web of Science ®Google Scholar
• Cherblanc FL, Davidson RW, Di Fruscia P, Srimongkolpithak N, Fuchter MJ. Perspectives on natural product epigenetic modulators in chemical biology and medicine. Nat Prod Rep 2013; 30:605 - 24; http://dx.doi.org/10.1039/c3np20097c; PMID: 23396528
   PubMed Web of Science ®Google Scholar
• Lee DC, Romero R, Kim JS, Tarca AL, Montenegro D, Pineles BL, Kim E, Lee J, Kim SY, Draghici S, et al. miR-210 targets iron-sulfur cluster scaffold homologue in human trophoblast cell lines: siderosis of interstitial trophoblasts as a novel pathology of preterm preeclampsia and small-for-gestational-age pregnancies. Am J Pathol 2011; 179:590 - 602; http://dx.doi.org/10.1016/j.ajpath.2011.04.035; PMID: 21801864
   PubMed Web of Science ®Google Scholar
• Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007; 129:1311 - 23; http://dx.doi.org/10.1016/j.cell.2007.05.022; PMID: 17604720
   PubMed Web of Science ®Google Scholar
• Pang RT, Leung CO, Ye TM, Liu W, Chiu PC, Lam KK, Lee KF, Yeung WS. MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells. Carcinogenesis 2010; 31:1037 - 44; http://dx.doi.org/10.1093/carcin/bgq066; PMID: 20351093
   PubMed Web of Science ®Google Scholar
• Umemura K, Ishioka S, Endo T, Ezaka Y, Takahashi M, Saito T. Roles of microRNA-34a in the pathogenesis of placenta accreta. J Obstet Gynaecol Res 2013; 39:67 - 74; http://dx.doi.org/10.1111/j.1447-0756.2012.01898.x; PMID: 22672425
   PubMed Web of Science ®Google Scholar
• Kumamoto K, Spillare EA, Fujita K, Horikawa I, Yamashita T, Appella E, Nagashima M, Takenoshita S, Yokota J, Harris CC. Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regulate mir-34a, mir-34b, and mir-34c expression, and induce senescence. Cancer Res 2008; 68:3193 - 203; http://dx.doi.org/10.1158/0008-5472.CAN-07-2780; PMID: 18451145
   PubMed Web of Science ®Google Scholar
• Swiatek PJ, Lindsell CE, del Amo FF, Weinmaster G, Gridley T. Notch1 is essential for postimplantation development in mice. Genes Dev 1994; 8:707 - 19; http://dx.doi.org/10.1101/gad.8.6.707; PMID: 7926761
   PubMed Web of Science ®Google Scholar
• Zhao WX, Lin JH. Notch signaling pathway and human placenta. Int J Med Sci 2012; 9:447 - 52; http://dx.doi.org/10.7150/ijms.4593
   PubMed Web of Science ®Google Scholar
• Hermeking H. The miR-34 family in cancer and apoptosis. Cell Death Differ 2010; 17:193 - 9; http://dx.doi.org/10.1038/cdd.2009.56; PMID: 19461653
   PubMed Web of Science ®Google Scholar
• Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N, Bentwich Z, Oren M. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 2007; 26:731 - 43; http://dx.doi.org/10.1016/j.molcel.2007.05.017; PMID: 17540598
   PubMed Web of Science ®Google Scholar
• Winn VD, Haimov-Kochman R, Paquet AC, Yang YJ, Madhusudhan MS, Gormley M, Feng KT, Bernlohr DA, McDonagh S, Pereira L, et al. Gene expression profiling of the human maternal-fetal interface reveals dramatic changes between midgestation and term. Endocrinology 2007; 148:1059 - 79; http://dx.doi.org/10.1210/en.2006-0683; PMID: 17170095
   PubMed Web of Science ®Google Scholar
• Caniggia I, Mostachfi H, Winter J, Gassmann M, Lye SJ, Kuliszewski M, Post M. Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFbeta(3). J Clin Invest 2000; 105:577 - 87; http://dx.doi.org/10.1172/JCI8316; PMID: 10712429
   PubMed Web of Science ®Google Scholar
• Sdassi N, Silveri L, Laubier J, Tilly G, Costa J, Layani S, Vilotte JL, Le Provost F. Identification and characterization of new miRNAs cloned from normal mouse mammary gland. BMC Genomics 2009; 10:149; http://dx.doi.org/10.1186/1471-2164-10-149; PMID: 19351399
   PubMed Web of Science ®Google Scholar
• Yan T, Liu Y, Cui K, Hu B, Wang F, Zou L. MicroRNA-126 regulates EPCs function: Implications for a role of miR-126 in preeclampsia. J Cell Biochem 2013; 114:2148 - 59; http://dx.doi.org/10.1002/jcb.24563; PMID: 23553946
   PubMed Web of Science ®Google Scholar
• Kumar P, Luo Y, Tudela C, Alexander JM, Mendelson CR. The c-Myc-regulated microRNA-17~92 (miR-17~92) and miR-106a~363 clusters target hCYP19A1 and hGCM1 to inhibit human trophoblast differentiation. Mol Cell Biol 2013; 33:1782 - 96; http://dx.doi.org/10.1128/MCB.01228-12; PMID: 23438603
   PubMed Web of Science ®Google Scholar
• Fu G, Brkić J, Hayder H, Peng C. MicroRNAs in Human Placental Development and Pregnancy Complications. Int J Mol Sci 2013; 14:5519 - 44; http://dx.doi.org/10.3390/ijms14035519; PMID: 23528856
   PubMed Web of Science ®Google Scholar
• Wang W, Feng L, Zhang H, Hachy S, Satohisa S, Laurent LC, Parast M, Zheng J, Chen DB. Preeclampsia up-regulates angiogenesis-associated microRNA (i.e., miR-17, -20a, and -20b) that target ephrin-B2 and EPHB4 in human placenta. J Clin Endocrinol Metab 2012; 97:E1051 - 9; http://dx.doi.org/10.1210/jc.2011-3131; PMID: 22438230
   PubMed Web of Science ®Google Scholar
• Muralimanoharan S, Maloyan A, Mele J, Guo C, Myatt LG, Myatt L. MIR-210 modulates mitochondrial respiration in placenta with preeclampsia. Placenta 2012; 33:816 - 23; http://dx.doi.org/10.1016/j.placenta.2012.07.002; PMID: 22840297
   PubMed Web of Science ®Google Scholar
• Gao WL, Liu M, Yang Y, Yang H, Liao Q, Bai Y, Li YX, Li D, Peng C, Wang YL. The imprinted H19 gene regulates human placental trophoblast cell proliferation via encoding miR-675 that targets Nodal Modulator 1 (NOMO1). RNA Biol 2012; 9:1002 - 10; http://dx.doi.org/10.4161/rna.20807; PMID: 22832245
   PubMed Web of Science ®Google Scholar
• Lázár L, Nagy B, Molvarec A, Szarka A, Rigó J Jr.. Role of hsa-miR-325 in the etiopathology of preeclampsia. Mol Med Rep 2012; 6:597 - 600; PMID: 22710575
   PubMed Web of Science ®Google Scholar
• Du R, Sun W, Xia L, Zhao A, Yu Y, Zhao L, Wang H, Huang C, Sun S. Hypoxia-induced down-regulation of microRNA-34a promotes EMT by targeting the Notch signaling pathway in tubular epithelial cells. PLoS One 2012; 7:e30771; http://dx.doi.org/10.1371/journal.pone.0030771; PMID: 22363487
   PubMed Web of Science ®Google Scholar
• Forman JJ, Legesse-Miller A, Coller HA. A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence. Proc Natl Acad Sci U S A 2008; 105:14879 - 84; http://dx.doi.org/10.1073/pnas.0803230105; PMID: 18812516
   PubMed Web of Science ®Google Scholar
• Pang RT, Leung CO, Lee CL, Lam KK, Ye TM, Chiu PC, Yeung WS. MicroRNA-34a is a tumor suppressor in choriocarcinoma via regulation of Delta-like1. BMC Cancer 2013; 13:25; http://dx.doi.org/10.1186/1471-2407-13-25; PMID: 23327670
   PubMed Web of Science ®Google Scholar
• Mondon F, Mignot TM, Rebourcet R, Jammes H, Danan JL, Ferré F, Vaiman D. Profiling of oxygen-modulated gene expression in early human placenta by systematic sequencing of suppressive subtractive hybridization products. Physiol Genomics 2005; 22:99 - 107; http://dx.doi.org/10.1152/physiolgenomics.00276.2004; PMID: 15797968
   PubMed Web of Science ®Google Scholar
• Vaiman D, Mondon F, Garcès-Duran A, Mignot TM, Robert B, Rebourcet R, Jammes H, Chelbi ST, Quetin F, Marceau G, et al. Hypoxia-activated genes from early placenta are elevated in preeclampsia, but not in Intra-Uterine Growth Retardation. BMC Genomics 2005; 6:111; http://dx.doi.org/10.1186/1471-2164-6-111; PMID: 16129025
   PubMed Web of Science ®Google Scholar
• Rao DS, O'Connell RM, Chaudhuri AA, Garcia-Flores Y, Geiger TL, Baltimore D. MicroRNA-34a perturbs B lymphocyte development by repressing the forkhead box transcription factor Foxp1. Immunity 2010; 33:48 - 59
   PubMed Web of Science ®Google Scholar
• Kohler PO, Bridson WE, Hammond JM, Weintraub B, Kirschner MA, Van Thiel DH. Clonal lines of human choriocarcinoma cells in culture. Acta Endocrinol Suppl (Copenh) 1971; 153:137 - 53; PMID: 5314233
   PubMedGoogle Scholar
• Jeanpierre M. A rapid method for the purification of DNA from blood. Nucleic Acids Res 1987; 15:9611; http://dx.doi.org/10.1093/nar/15.22.9611; PMID: 3684611
   PubMed Web of Science ®Google Scholar
• Holemon H, Korshunova Y, Ordway JM, Bedell JA, Citek RW, Lakey N, Leon J, Finney M, McPherson JD, Jeddeloh JA. MethylScreen: DNA methylation density monitoring using quantitative PCR. Biotechniques 2007; 43:683 - 93; http://dx.doi.org/10.2144/000112597; PMID: 18072598
   PubMed Web of Science ®Google Scholar
• Ordway JM, Bedell JA, Citek RW, Nunberg A, Garrido A, Kendall R, Stevens JR, Cao D, Doerge RW, Korshunova Y, et al. Comprehensive DNA methylation profiling in a human cancer genome identifies novel epigenetic targets. Carcinogenesis 2006; 27:2409 - 23; http://dx.doi.org/10.1093/carcin/bgl161; PMID: 16952911
   PubMed Web of Science ®Google Scholar
• Borghese B, Barbaux S, Mondon F, Santulli P, Pierre G, Vinci G, Chapron C, Vaiman D. Research resource: genome-wide profiling of methylated promoters in endometriosis reveals a subtelomeric location of hypermethylation. Mol Endocrinol 2010; 24:1872 - 85; http://dx.doi.org/10.1210/me.2010-0160; PMID: 20685852
   PubMed Web of Science ®Google Scholar